P. de Koning

777 total citations
20 papers, 613 citations indexed

About

P. de Koning is a scholar working on Cellular and Molecular Neuroscience, Oncology and Clinical Psychology. According to data from OpenAlex, P. de Koning has authored 20 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 4 papers in Oncology and 3 papers in Clinical Psychology. Recurrent topics in P. de Koning's work include Cancer Treatment and Pharmacology (4 papers), Nerve injury and regeneration (3 papers) and Regulation of Appetite and Obesity (2 papers). P. de Koning is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Nerve injury and regeneration (3 papers) and Regulation of Appetite and Obesity (2 papers). P. de Koning collaborates with scholars based in Netherlands, United States and Japan. P. de Koning's co-authors include Willem Hendrik Gispen, Jan H. Brakkee, F.G.I. Jennekens, J.P. Neijt, R. Gerritsen van der Hoop, W.H. Gispen, Epie Boven, Joost Verhaagen, G.H. Wieneke and Alexander C. van Huffelen and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, European Journal of Pharmacology and Experimental Neurology.

In The Last Decade

P. de Koning

20 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. de Koning Netherlands	9	292	141	118	116	69	20	613
Patrick Mouchet France	16	352 1.2×	208 1.5×	194 1.6×	58 0.5×	37 0.5×	34	678
Ilaria Roglio Italy	12	275 0.9×	262 1.9×	133 1.1×	96 0.8×	39 0.6×	13	738
Shanta E. Kapadia United States	9	398 1.4×	291 2.1×	145 1.2×	37 0.3×	28 0.4×	15	626
Viviana Triaca Italy	18	389 1.3×	199 1.4×	233 2.0×	83 0.7×	37 0.5×	42	855
Harriet Rönnholm Sweden	8	248 0.8×	86 0.6×	230 1.9×	38 0.3×	15 0.2×	11	625
Laurence W. Haynes United Kingdom	16	222 0.8×	147 1.0×	129 1.1×	14 0.1×	83 1.2×	32	546
Fredrik Lauritzen Norway	10	293 1.0×	200 1.4×	354 3.0×	35 0.3×	70 1.0×	10	798
Chyn‐Tair Lan Taiwan	17	169 0.6×	157 1.1×	204 1.7×	55 0.5×	69 1.0×	40	725
Mark Dunleavy Ireland	16	320 1.1×	94 0.7×	299 2.5×	29 0.3×	39 0.6×	21	682
Stuart L. Gibb United States	18	596 2.0×	105 0.7×	456 3.9×	39 0.3×	78 1.1×	28	1.2k

Countries citing papers authored by P. de Koning

Since Specialization

Citations

This map shows the geographic impact of P. de Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. de Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. de Koning more than expected).

Fields of papers citing papers by P. de Koning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. de Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. de Koning. The network helps show where P. de Koning may publish in the future.

Co-authorship network of co-authors of P. de Koning

This figure shows the co-authorship network connecting the top 25 collaborators of P. de Koning. A scholar is included among the top collaborators of P. de Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. de Koning. P. de Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heeringa, Marten, et al.. (2012). Serum Biomarkers in Nonalcoholic Steatohepatitis: Value for Assessing Drug Effects?. Biomarkers in Medicine. 6(6). 743–757. 7 indexed citations

Koning, P. de & James J. Keirns. (2009). Clinical Pharmacology, Biomarkers and Personalized Medicine: Education Please. Biomarkers in Medicine. 3(6). 685–700. 7 indexed citations

Koning, P. de, et al.. (1995). Clinical research in aggressive patients, pitfalls in study design and measurement of aggression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 19(6). 993–1017. 4 indexed citations

Olivier, Berend, et al.. (1994). Serenics. Birkhäuser Basel eBooks. 42. 167–308. 4 indexed citations

Moriarty, John, Bettina Schmitz, Michael Trimble, & P. de Koning. (1994). A trial of eltoprazine in the treatment of aggressive behaviours in two populations: Patients with epilepsy or Gilles de la Tourette's Syndrome. Human Psychopharmacology Clinical and Experimental. 9(4). 253–258. 4 indexed citations

Koning, P. de, et al.. (1992). ELTOPRAZINE IN AGGRESSIVE PSYCHOTIC AND PERSONALITY DISORDERED PATIENTS.. Clinical Neuropharmacology. 15. 373B–373B. 2 indexed citations

Vries, M. Hugo de, P. de Koning, A. Grahnén, et al.. (1991). Dose-proportionality of eltoprazine. European Journal of Clinical Pharmacology. 41(5). 485–488. 6 indexed citations

Koning, P. de, et al.. (1991). Problems in human aggression research.. PubMed. 3(2). S61–5. 3 indexed citations

Raghoebar, M., P. de Koning, Berend Olivier, et al.. (1990). Eltoprazine a serenic compound in development. European Journal of Pharmacology. 183(5). 1850–1851. 2 indexed citations

10.

Koning, P. de, et al.. (1989). Org.2766 stimulates collateral sprouting in the soleus muscle of the rat following partial denervation. Muscle & Nerve. 12(5). 353–359. 25 indexed citations

11.

Gispen, W.H., et al.. (1988). Peripheral nerve repair in the rat: functional and electrophysiological aspects. Utrecht University Repository (Utrecht University). 3 indexed citations

12.

Hoop, R. Gerritsen van der, et al.. (1988). A new approach for the evaluation of recovery after peripheral nerve damage. Journal of Neuroscience Methods. 26(2). 111–116. 15 indexed citations

13.

Hoop, R. Gerritsen van der, P. de Koning, Epie Boven, et al.. (1988). Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats. European Journal of Cancer and Clinical Oncology. 24(4). 637–642. 70 indexed citations

14.

Gispen, W.H., et al.. (1988). Melanocortins and peripheral nerve regeneration. Utrecht University Repository (Utrecht University). 2. 73–85. 1 indexed citations

15.

Koning, P. de, et al.. (1988). Estimation of the number of motor units based on macro-EMG.. Journal of Neurology Neurosurgery & Psychiatry. 51(3). 403–411. 42 indexed citations

16.

Gispen, Willem Hendrik, et al.. (1987). Chapter 28 On the neurotrophic action of melanocortins. Progress in brain research. 72. 319–331. 23 indexed citations

17.

Koning, P. de & Willem Hendrik Gispen. (1987). Org.2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides. 8(3). 415–422. 115 indexed citations

18.

Koning, P. de, J.P. Neijt, F.G.I. Jennekens, & Willem Hendrik Gispen. (1987). Org.2766 protects from cisplatin-induced neurotoxicity in rats. Experimental Neurology. 97(3). 746–750. 63 indexed citations

19.

Koning, P. de, et al.. (1987). Evaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in rats. Toxicology and Applied Pharmacology. 89(1). 81–87. 57 indexed citations

20.

Koning, P. de, Jan H. Brakkee, & Willem Hendrik Gispen. (1986). Methods for producing a reproducible crush in the sciatic and tibial nerve of the rat and rapid and precise testing of return of sensory function. Journal of the Neurological Sciences. 74(2-3). 237–246. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact